The Economics of Cardiac Failure

Overview

Journal J R Soc Med

Specialty General Medicine

Date 1996 Jan 1

PMID 8709091

Citations 2

Authors

F X Kleber

Affiliations

Soon will be listed here.

Abstract

Quality assurance and inclusion of prospective evaluation of costs of treatment in phase 3 and 4 pharmaceutical trials are becoming increasingly important. Not only high technology applications have to be investigated, but also relatively cheap but very common strategies for diagnostic work up and therapy. This may yield major savings. We are at the beginning of an era in which waste of resources may be reduced by scientific analysis with improvement in patient care and teaching achieved as a result.

Citing Articles

The economics of TRACE. A cost-effectiveness analysis of trandolapril in postinfarction patients with left ventricular dysfunction.

Lepen C, Lilliu H, Keller T, Fiessinger S Pharmacoeconomics. 1998; 14(1):49-58.

PMID: 10182194 DOI: 10.2165/00019053-199814010-00005.

Culture and medicine.

Swales J J R Soc Med. 1998; 91(3):118-26.

PMID: 9659321 PMC: 1296558. DOI: 10.1177/014107689809100302.

References

Munoz E, CHALFIN D, Birnbaum E, Mulloy K, Johnson H, Wise L . Hospital costs, resource characteristics, and the dynamics of death for patients with a primary diagnosis of congestive heart failure. N Y State J Med. 1989; 89(2):60-3. View

Loisance D, Benvenuti C, Lebrun T, Leclerc A, Tarral A, Sailly J . Cost and cost effectiveness of the mechanical and pharmacologic bridge to transplantation. ASAIO Trans. 1991; 37(3):M125-7. View

Poirier V . Can our society afford mechanical hearts?. ASAIO Trans. 1991; 37(4):540-4. View

Goodwin D . Critical pathways in home healthcare. J Nurs Adm. 1992; 22(2):35-40. DOI: 10.1097/00005110-199202000-00023. View

Kleber F, Niemoller L, Doering W . Impact of converting enzyme inhibition on progression of chronic heart failure: results of the Munich Mild Heart Failure Trial. Br Heart J. 1992; 67(4):289-96. PMC: 1024835. DOI: 10.1136/hrt.67.4.289. View

Tedder M, Anstadt M, Wharton J, Revishvili A, Hegde S, Lowe J . Prophylactic implantable defibrillator patches in patients at high risk for malignant ventricular dysrhythmias. ASAIO J. 1992; 38(3):M261-5. DOI: 10.1097/00002480-199207000-00033. View

Schneider J, Hornberger S, Booker J, Davis A, Kralicek R . A medication discharge planning program: measuring the effect on readmissions. Clin Nurs Res. 1993; 2(1):41-53. DOI: 10.1177/105477389300200105. View

Uretsky B, Young J, Shahidi F, Yellen L, Harrison M, Jolly M . Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: results of the PROVED trial. PROVED Investigative Group. J Am Coll Cardiol. 1993; 22(4):955-62. DOI: 10.1016/0735-1097(93)90403-n. View

Rodeheffer R, Jacobsen S, Gersh B, Kottke T, McCann H, Bailey K . The incidence and prevalence of congestive heart failure in Rochester, Minnesota. Mayo Clin Proc. 1993; 68(12):1143-50. DOI: 10.1016/s0025-6196(12)60063-9. View

10.

Reitsma J, Mosterd A, Koster R, van Capelle F, Grobbee D, Tijssen J . [Increase in the number of admissions due to heart failure in Dutch hospitals in the period 1980-1992]. Ned Tijdschr Geneeskd. 1994; 138(17):866-71. View

11.

Jonsson B . Improving patient care: consequences for resource allocation. Cardiology. 1994; 84(6):420-6. DOI: 10.1159/000176434. View

12.

van Hout B, Wielink G, Bonsel G, Rutten F . Effects of ACE inhibitors on heart failure in The Netherlands: a pharmacoeconomic model. Pharmacoeconomics. 1993; 3(5):387-97. DOI: 10.2165/00019053-199303050-00006. View

13.

Kulick D, Rahimtoola S . Risk stratification in survivors of acute myocardial infarction: routine cardiac catheterization and angiography is a reasonable approach in most patients. Am Heart J. 1991; 121(2 Pt 1):641-56. DOI: 10.1016/0002-8703(91)90747-6. View

14.

Kane R, Garrard J, BUCHANAN J, Rosenfeld A, Skay C, McDermott S . Improving primary care in nursing homes. J Am Geriatr Soc. 1991; 39(4):359-67. DOI: 10.1111/j.1532-5415.1991.tb02900.x. View

15.

SELLER R, Lobley M . Efficient diagnosis of common complaints: a comparative study in the United States and England. J Fam Pract. 1991; 33(1):41-6. View

16.

Cohn J, Johnson G, Ziesche S, Cobb F, Francis G, Tristani F . A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med. 1991; 325(5):303-10. DOI: 10.1056/NEJM199108013250502. View

17.

Matzuk M, Shlomchik M, Shaw L . Making digoxin therapeutic drug monitoring more effective. Ther Drug Monit. 1991; 13(3):215-9. DOI: 10.1097/00007691-199105000-00005. View

18.

Chapekis A, Burek K, Topol E . The cost:benefit ratio of acute intervention for myocardial infarction: results of a prospective, matched pair analysis. Am Heart J. 1989; 118(5 Pt 1):878-82. DOI: 10.1016/0002-8703(89)90217-2. View